Menu

Image of the Day: Malaria Hologram

Optical engineers have developed a portable field microscope that could aid the diagnosis of diseased cells.

Nov 5, 2017
The Scientist Staff, The Scientist Staff

Holographic microscope image depicting the differences between healthy human red blood cells (top row) and malaria-infected cells (bottom row)BAHRAM JAVIDI, UNIVERSITY OF CONNECTICUTResearchers at the University of Connecticut have developed a portable holographic microscope that could become a reliable tool for diagnosing diseased cells. 

The device could help medical workers in Africa and Asia identify patients suffering from malaria, where, there is often little access to necessary equipment for laboratory analysis of a blood sample in remote areas. Abnormalities in red blood cells formed by the malaria-causing parasite Plasmodium falciparum cause light to pass through them differently. The new microscope detects these nanoscale differences and is capable of visualizing them, whereas conventional light microscopes have limited ability to do so. The holograms created by the microscope could also be used for rapid analysis of cell abnormalities associated with sickle cell disease, HIV, and cancer.  

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.